BPC-157: How to Read a COA for Dogs

A certificate of analysis (COA) for a canine BPC-157 product answers one question: is the material in that bottle the peptide the label claims, at the purity and quantity claimed, within the contamination limits the lab tested for? Read it in four passes — identity (is this the right molecule), purity (how much of the peptide-related material is the target peptide), content (how much of the powder's weight is actually peptide rather than water and salts), and contamination (bioburden, endotoxin, residual solvents). Then check the two things most buyers skip: that the lot number on the document matches the lot on the bottle, and that the laboratory that signed the report is independent of the company selling the product.

That is the whole skill. Everything below is how to do each pass without being distracted by the parts of the document designed to look impressive.

What a COA is — and what it is not

A COA is an analytical report on one specific batch, produced by one specific laboratory, on one specific date. It is a factual record of measurements. It is not an approval, not an efficacy document, and not a statement that a compound is appropriate for any individual animal. BPC-157 and TB-500 are not FDA-approved veterinary drugs, and no COA changes that — the paperwork speaks to chemistry, not to regulatory status and not to your dog.

That distinction is worth holding onto, because it tells you what the document is genuinely useful for. A COA lets you rule out the failure mode that matters most in the peptide market: material that is not what the label says. Underfilled vials, degraded product, the wrong sequence, high residual solvent load, powder that is mostly counter-ion and moisture. Those are chemistry problems, and chemistry problems are exactly what a properly scoped COA catches.

What it cannot tell you is whether a peptide belongs in your dog's recovery. That is a conversation with your veterinarian, informed by the diagnosis, the imaging, the surgical plan if there is one, and whatever your dog is already taking.

Line by line: which entries actually carry information

Most COAs follow a similar layout. Some entries are load-bearing; others are decoration. Here is how to triage them.

COA line	What it tells you	What should prompt a question
Product name and peptide sequence	Whether the document describes the exact molecule, not a category	A trade name with no sequence or no molecular formula listed
Batch or lot number	Which physical production run was tested	No lot number, or a lot that does not match your bottle
Date of analysis	How recent the testing is relative to the batch	Undated reports, or one document reused across many batches
Appearance and physical form	Expected colour, state and solubility of the material	A description that does not match what you received
Identity by mass spectrometry	That the measured mass matches the theoretical mass for that sequence	Identity claimed with no method, or no observed value given
Purity by HPLC (% area)	The proportion of peptide-related material that is the target peptide	A purity figure with no chromatogram attached
Net peptide content	How much of the powder's mass is peptide rather than water and salts	Purity reported but content omitted entirely
Water content and counter-ion	The non-peptide fraction — moisture and residual acetate or TFA	Neither figure reported anywhere on the document
Microbial and endotoxin testing	Bioburden and bacterial endotoxin results against stated limits	Applicable tests listed as not performed with no explanation
Laboratory name, method and signature	Who ran the analysis and by what method	An unnamed lab, cropped letterhead, or a screenshot instead of a report

If a document is missing sequence, lot number, date, purity method and net peptide content, it is not a COA in any meaningful sense. It is a graphic.

Purity and peptide content are two different numbers

This is where most label confusion lives, and it is worth understanding properly because it is the number that touches dosing decisions.

HPLC purity, usually reported as percent area, describes the proportion of the peptide-related material in the sample that is the intended peptide. It is a relative measure — a ratio between the target peak and everything else the detector saw. A high purity figure means the synthesis and purification were clean, with few truncated chains, deletion sequences or oxidation products.

Net peptide content is a different question: of the total mass of powder in the vial, how much is peptide at all? Lyophilised peptides carry bound water, and they carry a counter-ion from purification — commonly acetate, sometimes trifluoroacetate. Both add mass. A vial can be genuinely high-purity and still contain meaningfully less peptide by weight than the number printed on the label suggests, because purity and content are answering different questions.

This is why a COA that reports purity but omits net peptide content leaves the actual quantity undefined. For a dog, where anything a veterinarian decides is weight-based, an undefined quantity is not a small gap. Ask for the content figure, and ask which counter-ion the material carries. A supplier that tests properly will have both.

Proving identity: mass, sequence and salt form

BPC-157 is a short chain of fifteen amino acids, a partial sequence derived from a protein found in gastric juice. TB-500 is a synthetic fragment corresponding to a biologically active region of thymosin beta-4. Because both are short, both are easy to get subtly wrong in synthesis — and easy to substitute.

Mass spectrometry is the identity check. The COA should state the theoretical mass calculated for that sequence and the observed mass measured in the sample, and the two should agree within the method's tolerance. If the report gives a theoretical value but no observed value, no identity test has actually been reported. If it names no method at all, treat the identity line as unverified.

The salt form should also be stated. It affects the mass balance, it affects the content calculation, and residual trifluoroacetate in particular is something a careful manufacturer measures and discloses rather than leaves silent. A document that tells you the sequence, the theoretical and observed mass, the purity method with its chromatogram, and the salt form has told you the chemistry. That is a real COA.

Independence, dates and lot matching — where documents go wrong

The most common problems with peptide COAs are not falsified numbers. They are structural.

An in-house report is not third-party testing. If the entity that manufactured or sells the product also generated the analysis, the document has no independence, however accurate it may be. Look for a named external laboratory with its own letterhead, its own methods and its own contact details.

An undated COA is not evidence about your bottle. Peptides degrade; batches vary. A report should carry a date of analysis and a batch identifier that you can match to the vial in your hand. One PDF circulated across every production run for two years tells you about a batch you will never receive.

A cropped chromatogram is a red flag. Purity claims should be supported by the actual trace, with axes visible and the peak table intact. A number with no trace behind it cannot be checked.

The same skepticism belongs on the shelf next to the peptides. Kitchen-sink joint chews that hide a dozen ingredients inside a proprietary blend, list no per-ingredient amount and publish no batch testing at all are asking for more trust than any peptide COA ever does — they simply ask for it quietly. A brand that publishes documents you can read is giving you something to argue with. That is the point.

From paperwork to administration — what verification does and does not decide

A clean COA changes practical handling. It tells you the physical form you should expect, whether the material arrives ready to use or requires reconstitution, what storage conditions the stated stability assumes, and how long the batch has been held. Those are the questions that determine whether a product is still what the document described by the time it reaches your dog.

What the COA does not decide is administration. Route, form, frequency, how any support product fits around a surgical repair, a rehab protocol, or prescribed medication such as carprofen or gabapentin — those are veterinary decisions, and dosing for a dog is weight-based and case-specific. There is no number here for a reason. Bring the COA to the appointment and let your veterinarian read it; a lab report is a far better basis for that conversation than a marketing page.

What research suggests about why owners are adopting these compounds sits alongside, not instead of, that plan. BPC-157 has been studied for its interaction with angiogenic and growth-factor signalling involved in soft-tissue and tendon repair, and TB-500 for actin-binding and cell-migration roles in tissue remodelling. That is emerging and genuinely promising science, and it is mechanism — not an outcome promise for any individual dog.

pawgen makes K9-REPAIR, a BPC-157 and TB-500 formulation made for dogs, with third-party testing, batch COAs, weight-based dosing guidance, direct-to-door shipping and a 60-day money-back guarantee. It is the stack many owners choose to run through a recovery period, and the documentation is published so it can be read the way this article describes.

Key Takeaways

• A COA is a batch-specific lab report — read it for identity, purity, content and contamination, in that order.
• Purity (percent area by HPLC) and net peptide content are different numbers; a document giving only the first leaves quantity undefined.
• Identity means a stated sequence plus a theoretical and observed mass from mass spectrometry, not a trade name.
• Match the lot number and date on the document to the bottle you actually received.
• Third-party means an independent named laboratory; an in-house report is not the same thing.
• Ask for the chromatogram. A purity figure with no trace behind it cannot be verified.
• The salt form and residual solvent disclosure tell you how carefully the material was finished.
• Dosing and administration questions resolve with your veterinarian, never with a number from a webpage.

A COA proves what is in the bottle; it never proves what a product will do for your dog — which is exactly why the diagnosis and the recovery plan stay with your veterinarian. Surgery, prescribed medication and structured rehabilitation are the backbone of orthopaedic and soft-tissue recovery in dogs, and nothing on a lab report changes that order of operations. Peptides and supplements operate inside the space that proper veterinary care creates. Read the paperwork so you know what you are handling, then hand it to the person who owns the plan.

For related reading on the TB-500 side of the formulation, see tb-500 dose for large dogs and tb-500 dose for giant breeds for dogs, or read more about K9-REPAIR.

Owners exploring peptide support for their dog can review K9-REPAIR — BPC-157 + TB-500 formulated for dogs — at https://pawgen.com/. BPC-157 and TB-500 are not FDA-approved veterinary drugs. Nothing in this article treats, cures or prevents any condition; every decision about your dog's care belongs with your veterinarian.